February 2021 - Page 3 of 14

ThursdayFeb 25, 2021 11:40 am

Mydecine Innovations Group Inc. (CSE: MYCO) (OTCQX: MYCOF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) is an emerging biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. The company's world-renowned medical and scientific advisory board is building out a robust R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols and unique delivery systems. Mydecine has exclusive access to a full cGMP-certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate and analyze active mushroom compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, Colorado,…

ThursdayFeb 25, 2021 11:35 am

Massroots Inc. (OTC: MSRT) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Massroots Inc. (OTC: MSRT) is a leading media company focused on the regulated cannabis industry, with a significant following and traffic across its online and social media platforms. MassRoots has been covered by CNBC, CNN, Financial Times, Wall Street Journal, New York Times, Reuters, Associated Press and Forbes. To learn more about the company, visit www.massrootsinvestors.com To view IBN’s virtual coverage of Benzinga’s upcoming Cannabis Capital Conference, visit https://ibn.fm/BenzingaCannabisFeb2021 For registration information and further details on this week’s conference, visit https://www.benzinga.com/events/cannabis/virtual/ About InvestorBrandNetwork’s Virtual Coverage The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, covers dozens of investor conferences…

ThursdayFeb 25, 2021 11:30 am

MagicMed Industries Inc. (CSE: MGIC) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

MagicMed Industries Inc. (CSE: MGIC - Reserved) is a biotechnology company founded in 2020. The company is focused on creating a library of novel derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline, ibogaine, MDMA and LSD. MagicMed’s molecular derivatives library, the Psybrary™, is intended to be an essential building block from which industry partners can develop new patented products. MagicMed is focused on the discovery and early development of novel drug candidates, structurally related to the classic psychedelics but with vastly improved pharmaceutical characteristics and commercial potential. To create the novel derivatives contained in the Psybrary™, the MagicMed team…

ThursdayFeb 25, 2021 11:25 am

KushCo Holdings Inc. (OTCQX: KSHB) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

KushCo Holdings Inc. (OTCQX: KSHB) is a premier provider of ancillary products and services to the legal cannabis and CBD industries. KushCo Holdings' subsidiaries and brands provide product quality, exceptional customer service, compliance knowledge and a local presence in serving its diverse customer base, which consists of leading multi-state-operators (MSOs), licensed producers (LPs) and brands. Founded in 2010, KushCo Holdings has now sold more than 1 billion units to growers, brand owners, processors and producers across North America, South America and Europe, specializing in child-resistant compatible and fully customizable packaging, exclusive vape hardware and technology, and complementary solvents and natural…

ThursdayFeb 25, 2021 11:20 am

Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Khiron Life Sciences Corp. (TSX.V: KHRN) (OTCQX: KHRNF) is a vertically integrated medical and CPG cannabis company with core operations in Latin America and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low- and high-THC medical cannabis products. The company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and it is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021. To learn more about…

ThursdayFeb 25, 2021 11:15 am

Jushi Holdings Inc. (CSE: JUSH) (OTCQB: JUSHF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Jushi Holdings Inc. (CSE: JUSH) (OTCQB: JUSHF) is a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. To learn more about the company, visit www.jushico.com To view IBN’s virtual coverage of Benzinga’s upcoming Cannabis Capital Conference, visit https://ibn.fm/BenzingaCannabisFeb2021 For registration information and further details on this week’s conference, visit https://www.benzinga.com/events/cannabis/virtual/ About InvestorBrandNetwork’s Virtual Coverage The InvestorBrandNetwork (“IBN”),…

ThursdayFeb 25, 2021 11:10 am

Item 9 Labs Corp. (OTCQX: INLB) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. With substantial insider investment, the company brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities and production innovation. Headquartered in Arizona, the company has 650,000+ square feet of operations space under development on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. To learn more about the company,…

ThursdayFeb 25, 2021 11:05 am

Indus Holdings Inc. (CSE: INDS) (OTCQX: INDXF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Indus Holdings Inc. (CSE: INDS) (OTCQX: INDXF) is a vertically integrated cannabis company with advanced production capabilities, including cultivation, extraction, manufacturing, brand sales & marketing, and distribution. Founded in 2014 and based in Salinas, California, Indus offers services supporting every step of the supply chain and an extensive portfolio of award-winning brands, including Cypress Cannabis, House Weed, The Original Pot Co., MOON, Humble Flower and Kaizen Medicinals. Indus Distribution, a division of Indus Holdings Inc., is a leading distributor of cannabis products, servicing an extensive portfolio of brands and licensed retailers. To learn more about the company, visit www.indusholdingsinc.com To…

ThursdayFeb 25, 2021 11:00 am

HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion's diverse product portfolio comprises 48 SKUs including tinctures, OTC topicals, doctor/practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion's wholly owned subsidiary, Probulin…

ThursdayFeb 25, 2021 10:40 am

Greater Cannabis Company Inc. (OTC: GCAN) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Greater Cannabis Company Inc. (OTC: GCAN) is a fully reporting publicly traded biopharmaceutical company focused on the development and commercialization of innovative cannabinoid delivery systems. Greater Cannabis deploys its technology platform for use in the cannabis industry. The company's conveyance platform can be utilized to deliver cannabinoids without the harmful side effects found with other routes of cannabinoid administration. The technology is versatile in that patients can receive lower dosing, enhanced bioavailability and controlled rapid and delayed release using non-irritant oral eluting and transdermal patches. Greater Cannabis' mission is to bring its technology to the global market through partnerships with…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: February 2021